QCG
RXST icon

Quadrant Capital Group’s RxSight RXST Stock Holding History

Quadrant Capital Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Sell
1,778
-246
-12% -$2.04K ﹤0.01% 2170
2025
Q4 		$21.1K Sell
2,024
-5,255
-72% -$52.7K ﹤0.01% 1971
2025
Q3 		$65.4K Buy
+7,279
New +$63.9K ﹤0.01% 1580
2025
Q2 		– Sell
-227
Closed -$5.73K – 2355
2025
Q1 		$5.73K Buy
+227
New +$6.75K ﹤0.01% 2327

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Quadrant Capital Group's RXST Position: Q1 2026 in Review

Quadrant Capital Group reduced its RxSight (RXST) stake by 12% in Q1 2026, selling an estimated $2.04K and leaving 1,778 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Quadrant Capital Group first reported a position in RXST in Q1 2025 and has held it in 4 quarters since. The position peaked at $65.4K in Q3 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Quadrant Capital Group held 1,778 shares of RxSight worth $11K as of Q1 2026.
  • Quadrant Capital Group sold 246 RxSight shares in Q1 2026, an estimated $2.04K.
  • RxSight made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2170 holding.
  • Quadrant Capital Group first reported a position in RxSight in Q1 2025 and has held it in 4 quarters since.
  • Quadrant Capital Group's RxSight position peaked at $65.4K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.